BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16249419)

  • 1. Relevance of urine telomerase in the diagnosis of bladder cancer.
    Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
    JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine telomerase activity for the detection of bladder cancer in females.
    Bravaccini S; Sanchini MA; Granato AM; Gunelli R; Nanni O; Amadori D; Calistri D; Silvestrini R
    J Urol; 2007 Jul; 178(1):57-61. PubMed ID: 17574060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of bladder cancer using telomerase activity in voided urine.
    Cheng CW; Chueh SC; Chern HD
    J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
    Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
    Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine telomerase: an important marker in the diagnosis of bladder cancer.
    Sanchini MA; Bravaccini S; Medri L; Gunelli R; Nanni O; Monti F; Baccarani PC; Ravaioli A; Bercovich E; Amadori D; Calistri D
    Neoplasia; 2004; 6(3):234-9. PubMed ID: 15153335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
    Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
    Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
    J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients.
    Casadio V; Bravaccini S; Gunelli R; Nanni O; Zoli W; Amadori D; Calistri D; Silvestrini R
    Int J Biol Markers; 2009; 24(4):253-7. PubMed ID: 20082275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
    Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
    J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
    Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
    Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
    Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
    Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
    Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A; Matuszewski M; Schlichtholz B
    Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
    Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
    Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study comparing various noninvasive methods of detecting bladder cancer in urine.
    Saad A; Hanbury DC; McNicholas TA; Boustead GB; Morgan S; Woodman AC
    BJU Int; 2002 Mar; 89(4):369-73. PubMed ID: 11872026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase Activity Analysis In Urine Sediment for Bladder Cancer.
    Casadio V; Bravaccini S
    Methods Mol Biol; 2021; 2292():133-141. PubMed ID: 33651358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of urinary molecular markers in bladder cancer.
    Eissa S; Swellam M; el-Mosallamy H; Mourad MS; Hamdy NΜ; Kamel K; Zaglol AS; Khafagy MM; el-Ahmady O
    Anticancer Res; 2003; 23(5b):4347-55. PubMed ID: 14666650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.
    Grossman HB; Soloway M; Messing E; Katz G; Stein B; Kassabian V; Shen Y
    JAMA; 2006 Jan; 295(3):299-305. PubMed ID: 16418465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.